Total Payments
$6,132
2024 Payments
$26.34
Companies
31
Transactions
420
Medicare Patients
2,485
Medicare Billing
$171,185
Payment Breakdown by Category
Food & Beverage$5,978 (97.5%)
Education$99.95 (1.6%)
Gifts$53.32 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,978 | 418 | 97.5% |
| Education | $99.95 | 1 | 1.6% |
| Gift | $53.32 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,799 | 127 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $587.77 | 37 | $0 (2021) |
| Allergan Inc. | $554.43 | 35 | $0 (2019) |
| PFIZER INC. | $338.36 | 26 | $0 (2021) |
| Gilead Sciences, Inc. | $326.66 | 26 | $0 (2021) |
| Janssen Biotech, Inc. | $281.18 | 24 | $0 (2022) |
| UCB, Inc. | $219.59 | 12 | $0 (2019) |
| QOL Medical, LLC | $200.18 | 12 | $0 (2021) |
| Braintree Laboratories, Inc. | $182.91 | 9 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $178.46 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.34 | 1 | Boston Scientific Corporation ($26.34) |
| 2022 | $185.80 | 6 | Janssen Biotech, Inc. ($99.95) |
| 2021 | $1,741 | 124 | AbbVie Inc. ($668.93) |
| 2020 | $635.30 | 40 | AbbVie Inc. ($273.98) |
| 2019 | $1,254 | 91 | AbbVie, Inc. ($277.29) |
| 2018 | $1,025 | 73 | AbbVie, Inc. ($285.09) |
| 2017 | $1,264 | 85 | Allergan Inc. ($350.54) |
All Payment Transactions
420 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: General - Enteral Feeding_ENDO | ||||||
| 08/12/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: INFLIXIMAB | ||||||
| 08/12/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: INFLIXIMAB | ||||||
| 03/25/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: INFLIXIMAB | ||||||
| 02/10/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: IMMUNOLOGY | ||||||
| 01/14/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/04/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Immunology | ||||||
| 12/20/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/15/2021 | Acacia Pharma Inc | BYFAVO (Drug), BARHEMSYS | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Anesthesiology | ||||||
| 12/14/2021 | Acacia Pharma Inc | BYFAVO (Drug), BARHEMSYS | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: Anesthesiology | ||||||
| 12/13/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Immunology | ||||||
| 12/13/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: Immunology | ||||||
| 12/10/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.07 | General |
| 12/09/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU, UCERIS | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Gastroenterology | ||||||
| 11/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/23/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.27 | General |
| 11/19/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/17/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Immunology | ||||||
| 11/11/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 20 | 1,177 | 1,295 | $717,964 | $88,920 |
| 2020 | 27 | 1,308 | 1,481 | $634,810 | $82,265 |
Total Patients
2,485
Total Services
2,776
Medicare Billing
$171,185
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 82 | 82 | $100,450 | $15,777 | 15.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 74 | 74 | $51,788 | $13,163 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 107 | $22,201 | $9,190 | 41.4% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 77 | 79 | $229,928 | $8,238 | 3.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 43 | 43 | $30,092 | $7,678 | 25.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 65 | 65 | $72,930 | $7,478 | 10.3% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 77 | 78 | $56,651 | $5,964 | 10.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 47 | 48 | $46,414 | $3,550 | 7.6% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 27 | 27 | $22,498 | $3,325 | 14.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $7,868 | $3,320 | 42.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 40 | $5,856 | $2,641 | 45.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $5,362 | $2,223 | 41.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 26 | $4,823 | $2,079 | 43.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $3,907 | $1,705 | 43.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 347 | 369 | $54,243 | $1,301 | 2.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 27 | 50 | $714.00 | $388.50 | 54.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 54 | 82 | $820.00 | $246.00 | 30.0% |
| 87324 | Detection test by immunoassay technique for clostridium difficile toxins (stool pathogen) | Office | 2021 | 15 | 20 | $520.00 | $239.60 | 46.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 19 | 21 | $483.00 | $221.76 | 45.9% |
| 87449 | Immunologic analysis for detection of organism by immunoassay technique, multiple-step method | Office | 2021 | 12 | 16 | $416.00 | $191.68 | 46.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 58 | 58 | $71,047 | $11,964 | 16.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 53 | 54 | $37,648 | $9,787 | 26.0% |
| 43249 | Balloon dilation of esophagus using an endoscope | Facility | 2020 | 66 | 74 | $212,528 | $8,492 | 4.0% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 59 | 60 | $67,320 | $7,778 | 11.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 70 | 87 | $16,974 | $6,289 | 37.0% |
About Dr. Thomas Dickinson, MD
Dr. Thomas Dickinson, MD is a Gastroenterology healthcare provider based in Provo, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376591354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Dickinson, MD has received a total of $6,132 in payments from pharmaceutical and medical device companies, with $26.34 received in 2024. These payments were reported across 420 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,978).
As a Medicare-enrolled provider, Dickinson has provided services to 2,485 Medicare beneficiaries, totaling 2,776 services with total Medicare billing of $171,185. Data is available for 2 years (2020–2021), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Provo, UT
- Active Since 05/04/2006
- Last Updated 11/27/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1376591354
Products in Payments
- HUMIRA (Biological) $507.82
- LINZESS (Drug) $492.31
- Humira (Biological) $452.01
- STELARA (Biological) $284.17
- XELJANZ (Drug) $282.85
- VIBERZI (Drug) $221.77
- Cimzia (Drug) $219.59
- CREON (Drug) $189.14
- Entyvio (Biological) $186.37
- Mavyret (Drug) $183.56
- ZENPEP (Drug) $177.34
- ENTYVIO (Biological) $147.91
- Creon (Drug) $133.33
- Sucraid (Drug) $118.54
- Amitiza (Drug) $115.31
- XIFAXAN (Drug) $99.58
- MAVYRET (Drug) $92.70
- NASCOBAL (Drug) $90.06
- GATTEX (Drug) $89.18
- OCALIVA (Drug) $86.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Provo
Brett Thorpe, Md, MD
Gastroenterology — Payments: $13,783
Gastroenterology $13,783
Kurt Bodily, Md, MD
Gastroenterology — Payments: $10,960
Gastroenterology $10,960
Brandon Dickinson, M.d, M.D
Gastroenterology — Payments: $5,178
Gastroenterology $5,178
Dr. Clarke Hilbig, M.d, M.D
Gastroenterology — Payments: $3,412
Gastroenterology $3,412
Gregory Craner, Md, MD
Gastroenterology — Payments: $15.13
Gastroenterology $15.13